Log In
BCIQ
Print this Print this
 

Cartiform

  Manage Alerts
Collapse Summary General Information
Company Osiris Therapeutics Inc.
DescriptionViable chondral allograft containing viable chondrocytes, chondrogenic growth factors, and extracellular matrix proteins
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentMarketed
Standard IndicationCartilage repair
Indication DetailsRepair damaged cartilage
Regulatory Designation
PartnerArthrex Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/17/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today